BELKIN Vision

BELKIN Vision is making waves in the health care industry with its innovative approach to glaucoma laser therapy. The company's slogan, "Accessible First-Line Glaucoma Care for All," captures its mission of providing accessible and efficient treatment for glaucoma. Founded in 2013 and headquartered in Israel, BELKIN Vision has developed the BELKIN Vision Eagle™, an efficient, non-contact, and automated glaucoma laser therapy device that is now available for sale in the EU and the UK. The company's recent Venture Round investment at 20 December 2021 saw participation from The European Innovation Council, signaling confidence in the company's vision and technology. With its focus on expanding access to glaucoma treatment, BELKIN Vision is poised to make a significant impact on ophthalmology. For further inquiries, contact [email protected].